Voyager Therapeutics, Inc. (BMV:VYGR)

Mexico flag Mexico · Delayed Price · Currency is MXN
68.00
0.00 (0.00%)
At close: Aug 14, 2025
Market Cap3.45B
Revenue (ttm)802.98M
Net Income (ttm)-2.04B
Shares Outn/a
EPS (ttm)-35.08
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume158
Average Volume706
Open68.00
Previous Closen/a
Day's Range68.00 - 68.00
52-Week Range58.00 - 68.00
Betan/a
RSI33.82
Earnings DateAug 7, 2025

About Voyager Therapeutics

Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. The company’s lead product candidate is VY7523, an anti-tau antibody program for the treatment of alzheimer’s disease (AD). Its product pipeline includes VY1706, a tau silencing gene therapy in preclinical trial for the treatment of alzheimer’s disease; SOD1 silencing gene therapy program for treating amyotrophic lateral sclerosis in preclinical trial; and vectorized anti-amyloid antibody early research program for the treat... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2013
Employees 172
Stock Exchange Mexican Stock Exchange
Ticker Symbol VYGR
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.